Body Hair Growth Research Articles

Prevalence, Awareness And Predisposing Factors For Polycystic Ovarian Syndrome (PCOS) Among Young Women In Selected PHC.

Background: Polycystic Ovary Syndrome (PCOS) is a common hormonal disorder that affects women during their reproductive years. It can cause irregular periods, excess androgen, and ovarian cysts. Aim: The aim of the study is to assess the prevalence, awareness and predisposing factors for Polycystic Ovarian Syndrome (PCOS) among young women in selected PHC. Methods: A quantitative approach and cross section study design was adopted for the study. The study included 300 young women with the age group of 18-30 years who are attending selected PHC, Salem. Convenient sampling technique was used for the study to select the samples. Data on menstrual cycle regularity, body hair growth, demographics, awareness, and predisposing factors for Polycystic Ovarian Syndrome were collected using a standard questionnaire and non-invasive sonographic scanning identified polycystic ovaries. Results: The prevalence of PCOS among young women was 20.67%, 39% of young women were aware of PCOS, 61 % were not aware about the PCOS. Among young women the age groups, 61.3% of women aged between 18-25 years and 38.7% of them aged between 26-30 years. In terms of Body Mass Index (BMI), 12.9% classified as underweight, 29% with a normal BMI, and 50% was classified as overweight. Activity levels also seem to influence PCOS, with 19.4% of individuals engaging in regular physical activity and 80.6% reporting no physical activity. Moreover, family history appears to play a role, as 83.9% of individuals with a family history of PCOS and 16.1% without such a history. Conclusion: PCOS is a common problem among young women after puberty. Many young women were unaware of the disease's symptoms and management, which may have skewed the observed disease burden away from its true prevalence.

Exploring natural ways to maintain keratin production in hair follicles

We are looking into natural ways to help hair grow better and stronger by studying keratin synthesis in human hair follicles. The reason for conducting this research was to have the ability to control hair growth through future innovations. We wanted to answer the question: How can we find natural ways to enhance hair growth by understanding the connection with natural resources, particularly keratin dynamics? The main focus of this experiment is understanding the promotion of keratin synthesis within human hair follicles, which is important for hair development and health. While keratin is essential for the growth and strength of body tissues, including skin and hair, our research hints at its specific synthesis within hair follicles. In our research utilizing castor oil, coconut oil, a turmeric and baking soda mixture, and a sugar, honey, and lemon mixture, we hypothesize that oils, specifically coconut oil and castor oil, will enhance keratin synthesis, whereas mixtures, such as the turmeric and baking soda mixture and the sugar, honey, and lemon mixture, will result in a decrease keratin synthesis. The methods used show how different natural substances influence keratin formation within the hair follicles. The experiment involved applying natural resources to hair strands and follicles, measuring their length under the microscope daily, and assessing their health and characteristics over seven days. In summary, our research helps us understand how hair grows better. We found that using natural items like essential oils effectively alters keratin growth within the hair follicles and hair strands.

STUDY OF PREVALENCE AND RISK FACTORS OF POLYCYSTIC OVARIAN SYNDROME AMONG ADOLESCENT AND YOUNG ADULTS OF RAMA UNIVERSITY

Background: There is little epidemiological data from India on the prevalence and risk factors associated with polycystic ovarian syndrome (PCOS). The objectives of the present study were to estimate the prevalence of PCOS using different criteria among adolescents and young women and to evaluate risk factors associated with PCOS. Materials and Methods: A total of 200 participants, adolescents (12-17 years, n = 100) and young women (18-30 years, n =100), were recruited. Participants who were overweight and having menstrual disorders or biochemical abnormalities were invited for ultrasonographic examination. A standardized questionnaire assessed the regularity of menstrual cycles, body hair growth, skin, body weight, sleep, and androgen excess. The ovarian volume and follicular size were assessed transabdominally. Prevalence of PCOS was assessed by the Rotterdam, AE-PCOS, and NIH criteria.Study period - 1st January 23 - 31st August 23 Results: The mean age of participants with PCOS was 21 ± 6.069 years and those without PCOS was 19.62±5.583 years. Mean body weight, body mass index, fasting insulin, systolic and diastolic blood pressures were significantly higher in the PCOS group. Prevalence of polycystic ovaries on ultrasonography was observed in 78.6% of the women with PCOS as against 5% in women without PCOS. Obesity (OR: 7.34, 95% CI: 1.95- 27.27), insulin resistance (OR:5.62, 95% CI :0.461 - 0.982) and hypertension (OR: 10.76, 95% CI: 0.916 - 0.998) were significantly associated with PCOS . Overall, the Prevalence of pcos was highest among female AGE GROUP 17-30YRS . Conclusion: There is a high prevalence of PCOS in today society, which emphasizes the need for urgent preventive and control measures. Early diagnosis and assessment of risk factor is therefore crucial in incorporating lifestyle and dietary modifications for weight reduction and better control of blood pressure at a younger age to further prevent long-term reproductive and metabolic disorders.

Pre-pubertal accelerometer-assessed physical activity and timing of puberty in British boys and girls: the Millennium Cohort Study.

Early puberty timing is associated with adverse health outcomes. We aimed to examine prospective associations between objectively measured physical activity and puberty timing in boys and girls. In the UK Millennium Cohort Study, physical activity volume and intensities at 7 years were measured using accelerometers. Status of several pubertal traits and age at menarche were reported at 11, 14 and 17 years. Age at menarche in girls was categorized into tertiles. Other puberty traits were categorized into earlier or later than the median ages calculated from probit models, separately in boys and girls. Multivariable regression models, with adjustment for maternal and child characteristics including body mass index (BMI) at age 7 years as potential confounders, were performed to test the associations of total daily activity counts and fractions of activity counts across intensities (in compositional models) with puberty timing, separately in boys (n = 2531) and girls (n = 3079). Higher total daily activity counts were associated with lower risks for earlier (vs later) growth spurt, body hair growth, skin changes and menarche in girls, and more weakly with lower risks for earlier skin changes and voice breaking in boys (odds ratios = 0.80-0.87 per 100 000 counts/day). These associations persisted on additional adjustment for BMI at 11 years as a potential mediator. No association with puberty timing was seen for any physical activity intensity (light, moderate or vigorous). More physical activity regardless of intensity may contribute to the avoidance of earlier puberty timing, independently of BMI, particularly in girls.

A Narrative Review on the Effect of Maternal Hypothyroidism on Fetal Development.

The thyroid is a butterfly-shaped gland located in the human body's neck region. The thyroid produces three hormones that are essential for regulating body temperature, energy production, weight, hair and nail growth, and menstrual cycle maintenance. The production of these hormones is controlled by a feedback mechanism. Various factors cause changes in the stimulation and inhibition of these hormones, which ultimately causes either excessive release or a decrease in the levels of thyroid hormones. These causes can be physiological or pathological. One of the physiological causes is pregnancy. Pregnancy is a very complex process in whichmany changes occur in the body and its functioning. One of which is changes in the maternal thyroid gland. The inability to adequately adapt to the changes leads to the abnormal functioning of the thyroid gland. During pregnancy, there is a variation in the concentration of thyroid hormones which may cause a decrease in levels or inhibition in the production of thyroid hormones. This condition is called hypothyroidism. Hypothyroidism in pregnant mothers can either be gestational or may be a condition that is present way before her pregnancy. Often, gestational hypothyroidism reverts after delivery during the postpartum period but can also be present as subclinical hypothyroidism. In such cases, they pose a significant threat to development, cause growth hindrance to the infant in the womb, and cause abnormalities in the offspringin the future. Some of the changes occur in the gland because of enhancement in levels of thyroid binding globulin, increased clearance rate of iodine from the body in kidneys, altered effects in human chorionic gonadotropin hormone, and decreased consumption of iodine in meals. Iodine disbalance in maternal hypothyroidism is associated with severe health issues like cretinism and mental retardation. Thyroid hormones are crucial for the infant's neural, cognitive, and intelligence quotient development in the womb. Thus, the disturbances in the maternal hormone levels disturb typical early developmental characteristics. In the world of rapidly advancing scientific research, there are many ways in which this condition can be detected early, diagnosed correctly, and given apt and required attention and treatment for causing the least harm to the fetus and the mother.

Idiopathic hirsutism: Is it really idiopathic or is it misnomer?

Hirsutism, which is characterized by excessive growth of terminal hair in a male pattern, may result from various causes including polycystic ovary syndrome (PCOS), non-classic congenital adrenal hyperplasia, adrenal or ovarian tumors or it may be idiopathic. Idiopathic hirsutism is currently defined as hirsutism associated with normal ovulatory function, normal serum androgen levels and normal ovarian morphology, however, the pathogenesis of idiopathic hirsutism is not clear. The androgens are the main hormones to stimulate growth of body hair, therefore, there should be any form of increased androgen effect irrespective of normal serum androgen levels in any patient with hirsutism. In accordance to this scientific truth, we have previously shown that, although within normal limits, patients with idiopathic hirsutism have relatively higher serum androgen levels (relative hyperandrogenemia) in comparison to healthy subjects which let as to think that is idiopathic hirsutism really idiopathic? In addition to relative hyperandrogenemia, we have previously shown that, in comparison to healthy subjects, women with idiopathic hirsutism demonstrated higher expression of steroid sulphatase and 17-beta hydroxysteroid dehydrogenase mRNA both in the subumbilical region and arm skin, which contributes to local androgen metabolism. Those results support the idea that, in some patients, although the adrenals or ovaries do not secrete increased amount of androgens leading to hyperandrogenemia, pilocebaceous unit locally produce increased amount of androgens leading to hirsutism without ovulatory dysfunction. Upon the demonstration of relative hyperandrogenemia and possible increase in local androgen synthesis in patients with idiopathic hirsutism, we think that idiopathic hirsutism is not idiopathic and it may be named as "normoandrogenic hirsutism". Furthermore, it may not be a different entity but may be an early stage of hyperandrogenic disorders such as PCOS. Clinically, this can be find out by following-up patients with idiopathic hirsutism prospectively.

Hypertrichosis associated with genetic conditions with head and neck alterations

INTRODUCTION: Hypertrichosis is a rare disorder in which there is an exaggerated growth of body hair in places that are not necessarily androgen-dependent, a particular feature of hirsutism. Its etiology is still questionable, with an increased incidence when associated with syndromes. This genetic association leads to numerous significant systemic and craniofacial changes, which should be recognized and considered by the dentist.OBJECTIVE: To assess, in databases, the presence of congenital hypertrichosis associated with genetic syndromes and conditions affecting the head and neck.METHODS: The search was conducted in PubMed-NCBI databases; genetic conditions along with their characteristics were available in Online Mendelian Inheritance in Man (OMIM) and in Protein®.RESULTS: The analysis was performed on 63 articles and all diseases were considered as rare. In the syndromes, prevalence of autosomal dominant inheritance was observed in 48.64%, followed by autosomal recessive in 45.9%, 1 X-linked recessive case, and 1 arising from defective mitochondrial energy generation. Among the 63 genetic conditions, 44 showed neurodevelopmental changes. Besides the craniofacial involvement itself, there is a high prevalence of alterations of the oral structures involving 47 of all conditions, including mainly dental abnormalities, palatal and gingival changes.CONCLUSION: The association of hypertrichosis with genetic components is strongly associated with major craniofacial changes. Therefore, the knowledge of the dental surgeon about the conditions that can affect the oral cavity is impressive because it is related to a correct treatment and better quality of life for the patient.

019 Multidisciplinary team and quality of life in transitional care

Gender affirming treatment for transgender people requires an interdisciplinary approach. Young people may receive pubertal suspension, consisting of gonadotrophin-releasing hormone analogs, later followed by sex steroids. The Endocrine Society clinical practice guidelines [1] for transgender women or those requesting feminization include estrogens in combination with androgen lowering medications. Feminizing treatment with estrogens and anti-androgens has desired physical changes, such as enhanced breast growth, reduction of facial and body hair growth and fat redistribution in a female pattern [2,3].

Somatic and Reproductive Health in Obese Adolescents

The purpose of the work was to study the somatic and gynecological history of obese adolescent girls. Materials and methods. Over the past 5 years, information has appeared about a change in the morbidity structure towards an increase in endocrine disorders, which significantly affect the development of gynecological pathology. We examined 120 adolescent girls aged 13 to 17 years. The main group included 100 obese girls; the control group included 20 non-obese girls. The formation of menstrual function in girls aged 13-17 years old was assessed on the basis of the following data: age of menarche, duration of the menstrual cycle, number of days of menstruation, intensity of blood loss, presence of pain syndrome. Height was measured on a vertical stadiometer (verified and approved for work). Determination of body weight was carried out using medical scales of any modification with a measurement range corresponding to the age characteristics of the patient. To assess the severity of obesity, all patients were determined by the body mass index according to Brey (1978) by the formula. Results and discussion. Somatic diseases were revealed in a significant amount in the subjects of the main group. An important factor should be noted both for girls of the main and control groups – the presence of 3-4 diseases is characteristic. Obese girls are characterized by a high incidence of gynecological diseases, especially inflammatory ones. Uterine hypoplasia was observed in 12 (12%) girls of the main group, polycystic ovary syndrome – in 16 (16%). The Ferriman-Gallwey index in adolescents in the main group was 9 (6.0 - 10.0), in the examined control group – 6 (5.0 - 7.0). The number of adolescent girls with increased body hair growth (Ferriman-Gallwey index above 8) in the main group was 77 (77%), which is significantly higher than in the control 2 (10%). 24 patients of the main group had a regular menstrual cycle from the moment of formation, in other cases violations were observed: irregularity – 43 (43%), painful menstruation – 61 (61%). The duration of the menstrual cycle was within the normal range in 18 (18%) adolescent girls in the main group and in 65% in the control group. The average cycle duration was 28±2.4 days and 28±1.3 days, respectively, for the groups. Conclusion. Our study showed a high incidence of somatic and reproductive diseases against the background of obesity in adolescents aged 13-17 years. As a result of analyzes of own research, a link was revealed between obesity and menstrual irregularities. We believe that the correction of body weight will lead to the normalization of the menstrual cycle, even without the use of additional therapy

Growth Hormone and the Human Hair Follicle.

Ever since the discoveries that human hair follicles (HFs) display the functional peripheral equivalent of the hypothalamic-pituitary-adrenal axis, exhibit elements of the hypothalamic-pituitary-thyroid axis, and even generate melatonin and prolactin, human hair research has proven to be a treasure chest for the exploration of neurohormone functions. However, growth hormone (GH), one of the dominant neurohormones of human neuroendocrine physiology, remains to be fully explored in this context. This is interesting since it has long been appreciated clinically that excessive GH serum levels induce distinct human skin pathology. Acromegaly, or GH excess, is associated with hypertrichosis, excessive androgen-independent growth of body hair, and hirsutism in females, while dysfunctional GH receptor-mediated signaling (Laron syndrome) is associated with alopecia and prominent HF defects. The outer root sheath keratinocytes have recently been shown to express functional GH receptors. Furthermore, and contrary to its name, recombinant human GH is known to inhibit female human scalp HFs’ growth ex vivo, likely via stimulating the expression of the catagen-inducing growth factor, TGF-β2. These limited available data encourage one to systematically explore the largely uncharted role of GH in human HF biology to uncover nonclassical functions of this core neurohormone in human skin physiology.

An Analysis of PCOS Disease Prediction Model Using Machine Learning Classification Algorithms

Background: Polycystic ovary syndrome is commonly known as PCOS and it is surprising that it affects up to 18% of women in reproductive age. PCOS is the most usually occurring hormone-related disorder. Some of the symptoms of PCOS are irregular periods, increased facial and body hair growth, attain more weight, darkening of skin, diabetes and trouble conceiving (infertility). It also came into light that patients suffering from PCOS also possess a range of metabolic abnormalities. Due to metabolic abnormalities, some disorder may occur which increase the risk of insulin resistance, type 2 diabetes and impaired glucose tolerance (a sign of prediabetes). Family members of women suffering from PCOS are also at higher hazardous level for developing the same metabolic abnormalities. Obesity and overweight status contribute to insulin resistance in PCOS. Objective: In the modern era, there are several new technologies available to diagnose PCOS and one of them is Machine learning algorithms because they are exposed to new data. These algorithms learn from past experiences to produce reliable and repeatable decisions. In this article, Machine learning algorithms are used to identify the important features to diagnose PCOS. Methods: Several classification algorithms like Support vector machine (SVM), Logistic Regression, Gradient Boosting, Random Forest, Decision Tree and K-Nearest Neighbor (KNN) are uses well organized test datasets for classify huge records. Initially a dataset of 541 instances and 41 attributes has been taken to apply the prediction models and a manual feature selection is done over it. Results: After the feature selection, a set of 12 attributes has been identified which plays a crucial role in diagnosing PCOS. Conclusion: There are several researches progressing in the direction of diagnosing PCOS but till now the relevant features are not identify for the same.

Characterizing the role of facial hair in gender identity and expression among transgender men

Characterizing the role of facial hair in gender identity and expression among transgender men

Prevalence of Polycystic Ovarian Syndrome Among Adolescents and Young Women in India

Background: There is little epidemiological data from India on the prevalence of polycystic ovarian syndrome (PCOS). The objectives of the present study were to estimate the prevalence of PCOS using different criteria among adolescents and young women and to evaluate risk factors associated with PCOS. Materials and Methods: A total of 518 participants, adolescents (12–17 years, n = 246) and young women (18–30 years, n = 272), were recruited. Participants who were overweight and having menstrual disorders or biochemical abnormalities were invited for ultrasonographic examination. A standardized questionnaire assessed the regularity of menstrual cycles, body hair growth, skin, body weight, sleep, and androgen excess. The ovarian volume and follicular size were assessed transabdominally. Prevalence of PCOS was assessed by the Rotterdam, AE-PCOS, and NIH criteria. Results: The mean age of participants with PCOS was 19.7±4.2 years and those without PCOS was 18.4±4.2 years. Mean body weight, body fat %, body mass index, waist circumference, systolic and diastolic blood pressures, and fasting insulin were significantly higher in the PCOS group. Prevalence of polycystic ovaries on ultrasonography was observed in 78.6% of the women with PCOS as against 5% in women without PCOS. Obesity (odds ratio (OR): 3.09, 95% confidence interval (CI): 1.32–7.21), insulin resistance (OR: 2.12, 95% CI: 1.12–4.0), and hypertension (OR: 4.46, 95% CI: 1.52–13.06) were significantly associated with PCOS (P < 0.05). The overall prevalence of PCOS was highest with 8.1% according to the Rotterdam criteria followed by AE-PCOS (2.9%) and NIH (2.1%). Irrespective of the criterion used, the prevalence increased with age. Conclusion: There is a high prevalence of PCOS in urban India, which emphasizes the need for urgent preventive and control measures. Early diagnosis is therefore crucial in incorporating lifestyle and dietary modifications for weight reduction and better control of blood pressure at a younger age to further prevent long-term reproductive and metabolic disorders.

Can Extra Adrenal Cortisol Secretion Occur in an Adrenalectomized Patient?

Abstract Background: Established medical practice is that adrenalectomized patients require lifelong steroid replacement. We report a case which challenges that assumption. Clinical Case: A 38 year old female underwent transsphenoidal resection of a proven ACTH secreting pituitary adenoma. Post operatively her pituitary function was preserved, but due to residual tumour activity and the desire to preserve fertility, she had a bilateral adrenalectomy one year later and commenced hydrocortisone replacement. Subsequent pituitary imaging did not show recurrence of the tumour and her visual fields were stable, however her ACTH remained elevated at 100 and 130ng/L (09:00 <50 ng/L) despite steroid replacement.14 years after adrenalectomy she noticed weight gain and increased body hair. She also reported sometimes missing her hydrocortisone due to her busy job without ill effects. Her 9 am cortisol pre-hydrocortisone was elevated at 333 nmol/L (9am: 140–690 nmol/L) with ACTH of 203.0 ng/L (09:00 <50ng/L) She was able to suppress cortisol normally after a Dexamethasone suppression test. CT of her adrenals found no adrenal tissue. By now she had weaned herself off hydrocortisone, keeping an emergency supply. SST showed a cortisol of 320 nmol/L at 30 minutes, 360 nmol/L at 60 minutes with an elevated ACTH of 140 ng/L (09:00 <50 ng/L). Her weight gain and body hair growth stabilised. Discussion: We have demonstrated that this adrenalectomized patient has ACTH driven endogenous cortisol secretion which may be due to residual adrenal tissue due to seeding after surgery or the presence of steroid synthesis elsewhere. Extra adrenal sources for glucocorticoid production are known such as skin, gonads and thymus. However, the levels are insufficient to mount a significant stress response. There is evidence of adrenal regeneration in adrenalectomized animals. The regeneration is primarily of the adrenal cortex and does not involve the medulla. There has been one case report in literature of a 11 year old German boy who had adrenal regeneration detected on adrenal scintigraphy (Bilateral normal adrenal glands with normal activity) 13 years after adrenalectomy for Cushing’s disease.

Abstract PS9-20: Prospective observational study of chemotherapy-induced alopecia after sequential FEC+taxane and the effects of age in breast cancer patients

Abstract BACKGROUND: Chemotherapy-induced alopecia (CIA) is a common and quite distressing adverse effects of chemotherapy. CIA, which can occurr not only in the scalp but also in the eyebrows, eyelashes, and pubic hair, has been known to be a transient condition. However, the degree, pattern, phenotype and processes of CIA are not fully known. CIA might be influenced by many factors, such as the specific chemotherapy regimen, drug doses, the patient’s age, and hormonal statuses. There are few detailed observational studies of CIA or of the impact of age on CIA. We performed a prospective observational study to investigate the prevalence and degree of CIA, including CIA of eyebrows, eyelashes, and body, and we examined patient’s recovery from CIA, focusing on age-depending effects. METHODS: We analyzed 68 female Japanese patients with breast cancer (median age 53 years, range 29-76 yrs) who received perioperative adjuvant chemotherapy with fluorouracil/epirubicin/cyclophosphamide (FEC) and taxane. A questionnaire was administered at the point of chemotherapy completion and 6 and 12 months after chemotherapy completion. The data collected by the questionnaire were as follows: the degree of alopecia, including the eyebrows, eyelashes, and body (pubic, leg, and axillary hair), the onset of alopecia, the onset of hair regrowth, and changes in hair characteristics (color, texture, thickness, structure). RESULTS: CIA occurred in all patients, with severe hair loss irrespective of age. CIA occurred mainly in the scalp but also in the eyebrows, eyelashes, and body for most of the patients. There were significant associations between the patient’s age and the onset of hair regrowth in the eyebrows, eyelashes, and body. The onset of eyebrows, eyelash, and body hair growth were significantly shorter in the premenopausal patients. Any hair changes (e.g., thinned diameter, softer texture, curlier structure) were reported by 85.3% of the patients. The changes in hair diameter were significantly more often ‘thinner’ in the menopausal group compared to the premenopausal group, but the changes in texture, structure, and color were not significantly different between these groups. CONCLUSIONS: Our results revealed the clinical process of CIA in early breast cancer patients who received standard chemotherapy. Severe CIA occurred in all 68 patients who received FEC and taxane chemotherapy. The present findings provide the first data demonstrating that age was not associated with the degree or incidence of hair loss, but age affected the recovery from CIA. These findings are important for the provision of more accurate information to patients who may undergo chemotherapy, and our data will contribute to the optimal treatment for CIA. Citation Format: Takaaki Fujii, Kei Ichiba, Chikako Honda, Yuko Nakazawa, Misato Ogino, Sasagu Kurozumi, Sayaka Obayashi, Reina Yajima. Prospective observational study of chemotherapy-induced alopecia after sequential FEC+taxane and the effects of age in breast cancer patients [abstract]. In: Proceedings of the 2020 San Antonio Breast Cancer Virtual Symposium; 2020 Dec 8-11; San Antonio, TX. Philadelphia (PA): AACR; Cancer Res 2021;81(4 Suppl):Abstract nr PS9-20.

Physical and Psychological Effects of Gender-Affirming Hormonal Treatment Using Intramuscular Testosterone Enanthate in Japanese Transgender Men.

IntroductionThe evidence on gender-affirming hormonal treatment (HT) for transgender persons is still insufficient.AimTo characterize the physical and psychological effects of HT using testosterone enanthate in transgender men, and to validate the safety of this treatment.MethodsA total of 85 Japanese transgender men who were followed up for at least 1 year at our gender clinic from 2004 to 2017 were included in this study. All self-reported effects that they recognized and regularly acquired laboratory data were investigated after initiation of HT.Main Outcome MeasureHT mainly using testosterone enanthate 250 mg every 2 weeks caused the most desired physical effects to appear promptly and effectively, whereas small but not negligible numbers of undesired physical and psychological effects were also confirmed.ResultsThe initial dose of testosterone enanthate was 250 mg for 72 (84.7%) subjects, and the injection interval was maintained every 2 weeks for 70 (82.3%). Most physical effects appeared within 6 months. A deepened voice (87.1%), cessation of menses (78.8%), acne (69.4%), and facial (52.9%)/body (37.6%) hair growth occurred within 3 months. Although recognition of psychological effects was rare, emotional instability (9.4%) and increased libido (7.1%) appeared in the relatively early phase after beginning HT. The mean values for red blood cells, hemoglobin, uric acid, and alkaline phosphatase were significantly increased for 2 year. During the observation period, there were no life-threatening adverse effects in any subjects.ConclusionThe present HT strategy is effective and safe for Japanese transgender men.The information from self-reported effects and objective data from blood tests can help both physicians and transgender men to understand testosterone HT.Kirisawa T, Ichihara K, Sakai Y, et al. Physical and Psychological Effects of Gender-Affirming Hormonal Treatment Using Intramuscular Testosterone Enanthate in Japanese Transgender Men. Sex Med 2021;9:100306.

Диагностика и тактика ведения пациенток с гиперандрогенией в раннем репродуктивном возрасте

Hyperandrogenism is characterized by the presence of clinical symptoms and / or biochemical parameters of high androgen levels. Dermopathy and particularly acne and hirsutism are regarded as the main clinical markers of hyperandrogenism. Cosmetic problems associated with hyperandrogenism are often the reason for young woman to seek medical attention. Body hair growth in atypical areas, acne and trophic skin changes have a significant effect on the emotional state, provoke a sense of imperfection and loss of attractiveness, and reduce the quality of life. Concomitant menstrual disorders (up to 50–75%) complicate the patient’s state and determine an increased risk of gynecological disorders in the future. The causes of hyperandrogenism in early reproductive age can be varied: from more common physiological hyperandrogenism in adolescence, idiopathic hyperandrogenism, polycystic ovary syndrome (PCOS) and the atypical form of congenital adrenal hyperplasia to less common hyperthecosis, acromegaly, hyperprolactinemia, hypothyroidism, Cushing’s disease, and androgen-secreting tumors. The diagnostic search should begin with assessing complaints and clinical symptoms, and a complete physical examination. To confirm biochemical hyperandrogenism, total and free testosterone, and free androgen index are evaluated. Additional methods of examination are used to clarify the diagnosis. Treatment is prescribed in accordance with the established diagnosis. Androgen-secreting tumors require surgical intervention. Other causes of hyperandrogenism are usually treated with medication. According to current recommendations, combined oral contraceptives are the first-line therapy for the most common conditions accompanied by hyperandrogenism (hirsutism, acne vulgaris, PCOS) in early reproductive age. A clinical solution may be a combined administration of microdoses of ethinylestradiol (20 μg) and drospirenone (3 mg), progestagen with antiandrogenic property in the mode 24 + 4 (for instance: Dimia). This article presents clinical cases of diagnosis and management tactics for patients of early reproductive age with hyperandrogenism. Conclusion. The differential diagnosis of physiological and pathological conditions accompanied by hyperandrogenism is one of the current challenges for obstetrician-gynecologist. A properly developed algorithm of examination, interpretation of its results, therapy and prevention of complications are of great importance. Key words: acne, alopecia acreata, congenital adrenal hyperplasia, hyperandrogenism, hirsutism, girls, drospirenone, combined oral contraceptives, contraception, adolescents, early reproductive age, polycystic ovary syndrome, ethinylestradiol

Ocular and extra-ocular complications following long-term steroid consumption in children with idiopathic nephrotic syndrome

Background: High dose of corticosteroids are required by patients with idiopathic nephrotic syndrome for long duration due to repeated relapse. The aims of this study were to analyze the ocular and extra-ocular complications of steroids on children with nephrotic syndrome.
 Methods: This cross-sectional study was conducted at Dhaka Shishu (Children) Hospital from September 2017 to September 2019. Children with nephrotic syndrome between 1-16 years of age, who received steroid for at least three months, participated in this study. Total 70 children were enrolled. Detailed history was taken from parents regarding initial episode, drug history, visual problem, headache, hypertension, weight gain, psychosis, bone pain, epigastric pain and excessive growth of body hair. Comprehensive opthalmologic assessment including visual acquity, intraocular pressure and cataract were performed. Detail of renal histopathology and treatment regimen in each patient was noted.
 Results: A total of 70 patients were included, 61.4% were male and 38.6% were female. Median age at the time of examination was 60 months (range 17 to 216 months). The mean duration of disease was 33.71±21.12 months. The mean cumulative steroid dose at the time of examination was 8485.91±7326.83 mg. Fourteen (20%) patients had posterior subcapsular cataract. Among 70 patients, we could do visual acuity for 25 (35.7%) patients, intraocular pressure (IOP) in mm for 51 (72.85%) patients. Among them raised IOP was found in five (9.8%) patients. In right eye mean IOP was 14.16±3.57 and for left eye 14.77±3.55 mm. Renal biopsy was performed in 15 (21.43%) cases. Among the biopsy report, it was found that mesangial proliferative glomerulonephritis (MPGN) in 8 (53.33%), focal segmental glomerulonephritis (FSGS) in 2 (13.33%) and minimal change in 5 (33.34%) cases. Among all cases, 12 (17.14%) patients developed Cushingoid facies, 3 (4.2%) patients had hypertrichosis, 3 (4.2%) patients had central obesity and 4 (5.7%) patients had buffalo hump but none had hypertension, diabetes mellitus, epigastric pain, bone pain or psychosis.
 Conclusion: Cataract formation was the most frequent ocular complication after large dose of oral corticosteroid therapy. The present study emphasizes the need for regular eye screening. Cushingoid facies was the most frequent among extra-ocular complications.
 Birdem Med J 2021; 11(1): 7-10

Pubertal onset with adulthood lung function mediated by height growth in adolescence.

BackgroundAge of pubertal onset is associated with height and lung function in adulthood. It is unknown whether height growth in adolescence mediates the association of age at puberty with early adult lung function.MethodsData from the Isle of Wight (IOW) birth cohort (n=1261) were examined in the study. Ages of pubertal events, height at ages 10 and 18 years and lung function parameters (forced vital capacity (FVC) and forced expiratory volume in 1 s (FEV1)) at 26 years were included in a path analysis to assess the mediation effects of height growth. Findings were tested in the Avon Longitudinal Study of Parents and Children (ALSPAC) birth cohort.ResultsIn females in the IOW cohort, age at menarche and body hair growth showed a positive indirect association with FVC (menarche: indirect effect coefficient (IEC)=0.13, 95% CI 0.05–0.20, p=1.28×10−3; body hair growth: IEC=0.08, 95% CI 0.01–0.15, p=0.017) and FEV1 (menarche: IEC=0.09, 95% CI 0.01–0.17, p=0.028; body hair growth: IEC=0.07, 95% CI 0.01–0.14, p=0.043) at 26 years through height growth and lung function at 18 years. In males, age at body hair growth (IEC=0.08; 95% CI 0.01–0.15, p=0.047), growth spurt (IEC=0.09; 95% CI 0.01–0.17, p=0.034) and facial hair growth (IEC=0.09; 95% CI 0.02–0.16, p=0.014) had positive indirect effects on FVC at 26 years, but voice deepening did not show statistically significant indirect effects (p>0.05). For pubertal events available in the ALSPAC cohort, results consistent with the IOW cohort were found for both females and males.ConclusionEffects of age of puberty on FVC in early adulthood are likely mediated by height growth during adolescence.

Prospective observational study of chemotherapy-induced alopecia after sequential FEC + taxane and the effects of age in breast cancer patients.

Chemotherapy-induced alopecia (CIA) is a common and quite distressing adverse effects of chemotherapy. There are few detailed observational studies of CIA or of the impact of age on CIA. We performed a prospective observational study to investigate the prevalence and degree of CIA, including CIA of eyebrows, eyelashes, and body, and we examined patient's recovery from CIA, focusing on age-depending effects. We analyzed 68 female Japanese patients with breast cancer (median age 53years, range 29-76 years) who received perioperative adjuvant chemotherapy with fluorouracil/epirubicin/cyclophosphamide (FEC) and taxane. A questionnaire was administered at the point of chemotherapy completion and 6 and 12months after chemotherapy completion. CIA occurred in all patients, with severe hair loss irrespective of age. CIA occurred mainly in the scalp but also in the eyebrows, eyelashes, and body for most of the patients. There were significant associations between the patient's age and the onset of hair regrowth in the eyebrows, eyelashes, and body. The onset of eyebrows, eyelash, and body hair growth were significantly shorter in the premenopausal patients. Any hair changes (e.g., thinned diameter, softer texture, curlier structure) were reported by 85.3% of the patients. Severe CIA occurred in all 68 patients who received FEC and taxane chemotherapy. The present findings provide the first data demonstrating that age was not associated with the degree or incidence of hair loss, but age affected the recovery from CIA. These results contribute more accurate information provision and insights regarding the proper treatment of CIA.